In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 second quarter ended December 31, 2021, on Tuesday, February 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: (877) 407-0789 (Domestic) (201) 689-8562 (International) The live conference call we...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the Sidoti December Virtual Micro Cap Investor Conference on December 8-9, 2021. Management will be available for one-on-ones throughout both days. Below are the details for Electromed’s group presentation: Sidoti December Virtual Micro Cap Investor Conference Date: Wednesday, Dece...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2021 (“Q1 FY 2022”). Q1 FY 2022 Highlights Net revenue increased 25.0% to $10.0 million, from $8.0 million for the three months ended September 30, 2020 (“Q1 FY 2021”), driven by 24.4% home care revenue growth and 61.5% institutional revenue growth. Gross profit percentage increased to 77.0% of net revenue, from 76.8% of net revenue in Q1 FY 2021. The inc...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 first quarter ended September 30, 2021, on Tuesday, November 9, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: (888) 428-7458 (Domestic) (862) 298-0702 (International) The live conference call web...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will nominate two new independent directors, Kathy Tune and Joe Galatowitsch, for election to its Board of Directors at the Company’s Fiscal 2022 Annual Meeting of Shareholders (the “Annual Meeting”), to be held in November. In connection with these nominations, Electromed has entered into a cooperation agreement with Summers Value Partners LLC (“Summers Value Partners”), an investment firm that beneficially o...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2021 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 9, 2021. About Electromed, Inc. Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, t...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2021”) and full year (“FY 2021”) ended June 30, 2021. Q4 FY 2021 Financial Highlights Net revenue increased 37.7% to $9.5 million, from $6.9 million for the three months ended June 30, 2020 (“Q4 FY 2020”), driven by 33.6% home care revenue growth and 90.6% growth in institutional sales. Operating income totaled $0.7 million, compared to $1.3 million in Q4 FY 2020. Th...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 fourth quarter ended June 30, 2021, on Tuesday, August 24, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: (877) 407-9753 (Domestic) (201) 493-6739 (International) The live conference call webcast ...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today confirmed that Summers Value Partners has provided notice of its intent to nominate four candidates to stand for election to the Electromed Board of Directors at its Fiscal 2022 Annual Meeting of Shareholders (the “Annual Meeting”). Members of Electromed’s Board and management team have been engaged in an ongoing dialogue with Summers Value Partners, and the Board will consider these director nominees with a focus on serving t...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced select preliminary unaudited financial results for the three months ended June 30, 2021 (“Q4 FY 2021”). For Q4 FY 2021, the Company expects to report: Net revenue of between $9.3 million and $9.5 million, compared to $6.9 million for the three months ended June 30, 2020 (“Q4 FY 2020”), driven primarily by strong growth in home care revenue. Operating income of between $0.5 million and $0.7 million, compared to $...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in Canaccord Genuity’s 41st Annual Growth Conference, to be held virtually, on August 10-12, 2021. Below are the details for Electromed’s group presentation: Date: Wednesday, August 11, 2021 Time: 10:00am Eastern Time Webcast link: A link to the webcast also will be available...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has approved a $3.0 million stock repurchase authorization, effective as of May 26, 2021. Under the authorization, the Company may repurchase common stock, par value $0.01 per share, with an aggregate value of up to $3.0 million through May 26, 2022. The authorization does not obligate the Company to repurchase any particular amount of common stock, and it could be modified, suspended, or ...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (NYSE American: ELMD) was named Quality Magazine’s 2021 Plant of the Year. Electromed was selected for the honor from the 2021 Quality Leadership Top 100 Company survey published annually by the magazine. The metrics measure and showcase quality leadership such as: continuous improvement and internal quality programs; contribution of quality to profitability and shareholder value; average number of hours that employees receive quality training; scrap and rework as a percentage of sales; warranty costs as a percentage of sales; and registra...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced its financial results for the three months ended March 31, 2021 (“Q3 FY 2021”). Q3 FY 2021 Highlights Net revenue increased 0.5% to $8.8 million, compared to $8.7 million during the three months ended March 31, 2020 (“Q3 FY 2020”), driven by a 4.2% increase in home care revenue. Gross profit percentage increased to 76.3% of net revenue, compared to 75.4% in Q3 FY 2020, primarily due to a higher mix of home care ...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 third quarter ended March 31, 2021, on Tuesday, May 11, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: (877) 407-9753 (Domestic) (201) 493-6739 (International) The live conference call webcast wil...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the Sidoti Spring 2021 Virtual Investor Conference on March 24-25, 2021. Management will be available for one-on-ones throughout both days. Below are the details for Electromed’s group presentation: Sidoti Spring 2021 Virtual Investor Conference Date: Wednesday, March 24, 2021 Tim...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2020 (“Q2 FY 2021”). Q2 FY 2021 Highlights Net revenue increased 11.1% to $9.5 million, compared to $8.5 million during the three months ended December 31, 2019 (“Q2 FY 2020”), driven by a 16.1% increase in home care revenue. Gross profit percentage increased to 79.2% of net revenue, compared to 78.1% in Q2 FY 2020, primarily due to a higher mix of home c...
NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 second quarter ended December 31, 2020 on Tuesday, February 9, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: (877) 407-9753 (Domestic) (201) 493-6739 (International) The live conference call webc...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.